Skip to main content
Hua Medicine logo

Hua Medicine — Investor Relations & Filings

Ticker · 2552 HKEX Manufacturing
Open in API
Filings indexed 296 across all filing types
Latest filing 2026-04-22 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 2552

About Hua Medicine

http://www.huamedicine.com

Hua Medicine is an innovative drug development and commercialization company focused on creating novel therapies for patients with unmet medical needs globally. The company specializes in leading innovation in diabetes care. Its core commercialized product is HuaTangNing® (dorzagliatin), a first-in-class Glucokinase Activator (GKA) approved for the treatment of Type 2 Diabetes (T2D). Dorzagliatin functions by targeting the glucose sensor Glucokinase to restore glucose homeostasis and improve glucose sensitivity. A key clinical advantage is its suitability for T2D patients with renal impairment, as it requires no dose adjustment. Beyond diabetes, the company's pipeline includes mGluR5 NAM (Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator), a potential novel treatment for L-Dopa-induced dyskinesia in Parkinson's disease.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is not the full Annual Report or Circular itself but a notification letter to non-registered holders informing them that the Annual Report 2025 and related circulars are available on the company and HKEX websites, with instructions for requesting printed copies. This is a publication announcement of corporate communications rather than the report itself. According to the menu vs meal rule, this is a Report Publication Announcement (RPA).
2026-04-22 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM
Report Publication Announcement Classification · 1% confidence The document is a shareholder notification letter informing registered shareholders that the Company’s Annual Report 2025, related Circular (including proposals for director re-election, share mandates, auditor re-appointment, amended constitutional documents), the AGM notice, and proxy form (collectively “Current Corporate Communication”) have been published online and explaining how to obtain printed or electronic copies. It does not contain the actual financial statements or meeting materials but is a notice of publication. Under the “Menu vs Meal” rule, this is an announcement of report availability rather than the report itself, classifying it as a Report Publication Announcement (RPA).
2026-04-22 English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, JUNE 25, 2026
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a form of proxy related to the Annual General Meeting on June 25, 2026, providing resolutions and voting instructions to shareholders. It is a solicitation of votes and informational material sent to shareholders ahead of the AGM. This matches the definition of 'Proxy Solicitation & Information Statement (PSI).'
2026-04-22 English
(I) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (II) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES; (III) PROPOSED RE-APPOINTMENT OF AUDITOR; (IV) PROPOSED ADOPTION OF
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a circular sent to shareholders in advance of the Annual General Meeting detailing resolutions to be voted on (re-election of directors, share mandates, auditor re-appointment, amendments to articles of association) and includes a form of proxy and notice of the AGM. This corresponds to proxy solicitation and information materials rather than the report itself or a results announcement. Therefore, it should be classified as a Proxy Solicitation & Information Statement.
2026-04-22 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Notice of Annual General Meeting including agenda items, resolutions to be voted on, proxy instructions, form deposits and meeting logistics. It is sent to shareholders to request votes and provide information for the upcoming meeting, rather than the full report or meeting materials itself. This matches the Proxy Solicitation & Information Statement category.
2026-04-22 English
Environmental, Social and Governance Report 2025
Environmental & Social Information Classification · 1% confidence The document is titled “2025 Environmental, Social and Governance Report” and contains detailed ESG disclosures, including governance structure, environmental management, social initiatives, climate-related disclosures, stakeholder engagement, and ESG data summaries. It follows ESG reporting frameworks and covers non‐financial sustainability topics rather than financial results, management changes, or regulatory filings. Therefore, it is an Environmental & Social Information report.
2026-04-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.